Why Novavax Stock Is Sinking Again This Week
Shares of Novavax (NASDAQ: NVAX) are sinking 13.8% this week as of the market close Thursday, based on data from S&P Global Market Intelligence. This decline came even though Novavax didn't make any new announcements in recent days.
Perhaps the most likely reason for the stock continuing to drop relates to news from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). The two partners announced on Tuesday the initiation of a clinical study evaluating a version of their COVID-19 vaccine targeting the coronavirus omicron variant.
Image source: Getty Images.
Source Fool.com
